AGA Accepting Applications for Its Inaugural Incubator Program

AUGUST 21, 2025

Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

AUGUST 20, 2025

Highlights From DDW 2025, Part 2

AUGUST 19, 2025

Email This Article

POSTED: JULY 14, 2023

Combination Therapy Reduces Readmissions for Overt Hepatic Encephalopathy

Use of rifaximin within 30 days of discharge is related to lower readmissions in patients with overt hepatic encephalopathy, according to a retrospective study.
A link to this article will be included in this email.

Recipient's Email Address:

Enter email addresses separated by commas if sending to more than one person. (200 characters max)

Your Name:

Your Email Address:

Send me a copy

Personal Message: (Optional)

These email addresses will only be used to send out this message.

Please wait..

Multimedia

JULY 14, 2023

Combination Therapy Reduces Readmissions for Overt Hepatic Encephalopathy

To read the full story, Log in or Sign up for a Free Account

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select